Intrinsic Transcriptional Activation-Inhibition Domains of the Polyomavirus Enhancer Binding Protein 2/Core Binding Factor α Subunit Revealed in the Presence of the β Subunit

REFERENCES

• Aronson, B. D., A. L. Fisher, K. Blechman, M. Caudy, and J. P. Gergen 1997. Groucho-dependent and -independent repression activities of Runt domain proteins. Mol. Cell. Biol. 17: 5581–5587.
   PubMed Web of Science ®Google Scholar
• Bae, S. C., Y. Yamaguchi-Iwai, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito 1993. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8: 809–814.
   PubMed Web of Science ®Google Scholar
• Bae, S. C., E. Ogawa, M. Maruyama, H. Oka, M. Satake, K. Shigesada, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, and Y. Ito 1994. PEBP2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol. 14: 3242–3252.
   PubMed Web of Science ®Google Scholar
• Brown, H. J., J. A. Sutherland, A. Cook, A. J. Bannister, and T. Kouzarides 1995. An inhibitor domain in c-Fos regulates activation domains containing the HOB1 motif. EMBO J. 14: 124–131.
   PubMedGoogle Scholar
• Bruhn, L., A. Munnerlyn, and R. Grosschedl 1997. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRα enhancer function. Genes Dev. 11: 640–653.
   PubMed Web of Science ®Google Scholar
• Cao, Z., R. M. Umek, and S. L. MacKnight 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5: 1538–1552.
   PubMed Web of Science ®Google Scholar
• Castilla, L. H., C. Wijmenga, Q. Wang, T. Stacy, N. A. Speck, M. Eckhaus, M. Marin-Padilla, F. S. Collins, A. Wynshaw-Boris, and P. P. Liu 1996. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87: 687–696.
   PubMed Web of Science ®Google Scholar
• Chen, C., and H. Okayama 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745–2752.
   PubMed Web of Science ®Google Scholar
• Dingwall, C., and R. A. Laskey 1991. Nuclear targeting sequences—a consensus? Trends Biochem. Sci. 16: 478–481.
   PubMed Web of Science ®Google Scholar
• Dubendorff, J. W., L. J. Whitaker, J. T. Eltman, and J. S. Lipsick 1992. Carboxy-terminal elements of c-Myb negatively regulate transactivational activation in cis and in trans. Genes Dev. 6: 2524–2535.
   PubMed Web of Science ®Google Scholar
• Ducy, P., R. Zhang, V. Geoffroy, A. L. Ridall, and G. Karsenty 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747–754.
   PubMed Web of Science ®Google Scholar
• Era, T., N. Asou, T. Kunisada, H. Yamasaki, H. Asou, N. Kamada, S. Nishikawa, K. Yamaguchi, and K. Takatsuki 1995. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes Chromosomes Cancer 13: 25–33.
   PubMed Web of Science ®Google Scholar
• Erickson, P., J. Gao, K. S. Chang, T. Look, E. Whisenant, S. Raimondi, R. Lasher, J. Trujillo, J. Rowley, and H. Drabkin 1992. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80: 1825–1831.
   PubMed Web of Science ®Google Scholar
• Forman, B. M., K. Umesono, J. Chen, and R. M. Evans 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81: 541–550.
   PubMed Web of Science ®Google Scholar
• Frank, R., J. Zhang, H. Uchida, S. Meyers, S. W. Hiebert, and S. D. Nimer 1995. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 11: 2667–2674.
   PubMed Web of Science ®Google Scholar
• Fujii, M., H. Tsuchiya, and M. Seiki 1991. HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity. Oncogene 6: 2349–2352.
   PubMedGoogle Scholar
• Ghozi, M. C., Y. Bernstein, V. Negreanu, D. Levanon, and Y. Groner 1996. Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc. Natl. Acad. Sci. USA 93: 1935–1940.
   PubMed Web of Science ®Google Scholar
• Giese, K., C. Kingsley, J. R. Kirshner, and R. Grosschedl 1995. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9: 995–1008.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., G. F. Barker, S. K. Bohlander, S. W. Hiebert, D. C. Ward, P. Bray-Ward, E. Morgan, S. C. Raimondi, J. D. Rowley, and D. G. Gilliland 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 92: 4917–4921.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W., W. Sun, J. N. Davis, T. Golub, S. Shurtleff, A. Buijs, J. R. Downing, G. Grosveld, M. F. Roussel, D. G. Gilliland, N. Lenny, and S. Meyers 1996. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 16: 1349–1355.
   PubMed Web of Science ®Google Scholar
• Ito, Y., and S.-C. Bae The Runt domain transcription factor, PEBP2/CBF, and its involvement in human leukemia Oncogenes as transcriptional regulators In: Yaniv, M., and J. Ghysdael21997107–132Birkhauser Verlag, Basel, Switzerland.
   Google Scholar
• Kagoshima, H., Y. Akamatsu, Y. Ito, and K. Shigesada 1996. Functional dissection of the alpha and beta subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. J. Biol. Chem. 271: 33074–33082.
   PubMedGoogle Scholar
• Kanno, Y., T. Kanno, and Y. Ito. Unpublished data.
   Google Scholar
• Kim, W.-Y., and Y. Ito. Unpublished data.
   Google Scholar
• Klampfer, L., J. Zhang, A. O. Zelenetz, H. Uchida, and S. D. Nimer 1996. The AML1/ETO fusion protein activates transcription of BCL-2. Proc. Natl. Acad. Sci. USA 93: 14059–14064.
   PubMed Web of Science ®Google Scholar
• Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. A. Maki 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61: 113–124.
   PubMed Web of Science ®Google Scholar
• Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R. T. Bronson, Y. H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755–764.
   PubMed Web of Science ®Google Scholar
• Kowenz-Leutz, E., G. Twamley, S. Ansieau, and A. Leutz 1994. Novel mechanism of C/EBPβ (NF-M) transactivational control: activation through derepression. Genes Dev. 8: 2781–2791.
   PubMed Web of Science ®Google Scholar
• Krimpenfort, P., R. de Jong, Y. Uematsu, Z. Dembic, S. Ryser, H. von Boehmer, M. Steinmetz, and A. Berns 1988. Transcription of T cell receptor β-chain genes is controlled by a downstream regulatory element. EMBO J. 7: 745–750.
   PubMedGoogle Scholar
• Liu, P., S. A. Tarle, A. Hajra, D. F. Claxton, P. Marlton, M. Freedman, M. J. Siciliano, and F. S. Collins 1993. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 261: 1041–1044.
   PubMed Web of Science ®Google Scholar
• Lu, J., M. Maruyama, M. Satake, S. C. Bae, E. Ogawa, H. Kagoshima, K. Shigesada, and Y. Ito 1995. Subcellular localization of the α and β subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol. Cell. Biol. 15: 1651–1661.
   PubMed Web of Science ®Google Scholar
• Mayall, T. P., P. L. Sheridan, M. R. Montminy, and K. A. Jones 1997. Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro. Genes Dev. 11: 887–899.
   PubMed Web of Science ®Google Scholar
• Merriman, H. L., A. J. van Wijnen, S. Hiebert, J. P. Bidwell, E. Fey, J. Lian, J. Stein, and G. S. Stein 1995. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/Runt domain transcription factor family: interpretations with the osteocalcin gene promoter. Biochemistry 34: 13125–13132.
   PubMed Web of Science ®Google Scholar
• Meyers, S., N. Lenny, and S. W. Hiebert 1995. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15: 1974–1982.
   PubMed Web of Science ®Google Scholar
• Milner, J., B. Ponder, L. Hughes-Davies, M. Seltmann, and T. Kouzarides 1997. Transcriptional activation functions in BRCA2. Nature 386: 772–773.
   PubMed Web of Science ®Google Scholar
• Miyoshi, H., K. Shimizu, T. Kozu, N. Maseki, Y. Kaneko, and M. Ohki 1991. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88: 10432–10434.
   Google Scholar
• Miyoshi, H., T. Kozu, K. Shimizu, K. Enomoto, N. Maseki, Y. Kaneko, N. Kamada, and M. Ohki 1993. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 12: 2715–2721.
   PubMed Web of Science ®Google Scholar
• Miyoshi, H., M. Ohira, K. Shimizu, K. Mitani, H. Hirai, T. Imai, K. Yokoyama, E. Soeda, and M. Ohki 1995. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res. 23: 2762–2769.
   PubMed Web of Science ®Google Scholar
• Mizushima, S., and S. Nagata 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18: 5322.
   PubMed Web of Science ®Google Scholar
• Mundlos, S., F. Otto, C. Mundlos, J. B. Mulliken, A. S. Aylsworth, S. Albright, D. Lindhout, W. G. Cole, W. Henn, J. H. Knoll, M. J. Owen, R. Mertelsmann, B. U. Zabel, and B. R. Olsen 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773–779.
   PubMed Web of Science ®Google Scholar
• Nerlov, C., and E. B. Ziff 1994. Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-α on the serum albumin promoter. Genes Dev. 8: 350–362.
   PubMedGoogle Scholar
• Niki, M., H. Okada, H. Takano, J. Kuno, K. Tani, H. Hibino, S. Asano, Y. Ito, M. Satake, and T. Noda 1997. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcriptional factor, polyomavirus enhancer binding protein 2/core binding factor. Proc. Natl. Acad. Sci. USA 94: 5697–5702.
   PubMedGoogle Scholar
• Ogawa, E., M. Inuzuka, M. Maruyama, M. Satake, M. Naito-Fujimoto, Y. Ito, and K. Shigesada 1993. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 194: 314–331.
   PubMed Web of Science ®Google Scholar
• Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90: 6859–6863.
   PubMed Web of Science ®Google Scholar
• Ogawa, E., and Y. Ito. Unpublished data.
   Google Scholar
• Okuda, T., J. van Deursen, S. W. Hiebert, G. Grosveld, and J. R. Downing 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321–330.
   PubMed Web of Science ®Google Scholar
• Otto, F., A. P. Thornell, T. Crompton, A. Denzel, K. C. Gilmour, I. R. Rosewell, G. W. H. Stamp, R. S. P. Beddington, S. Mundlos, B. R. Olsen, P. B. Selbey, and M. J. Owen 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765–771.
   PubMed Web of Science ®Google Scholar
• Rhoades, K. L., C. J. Hetherington, J. D. Rowley, S. W. Hiebert, G. Nucifora, D. G. Tenen, and D. E. Zhang 1996. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc. Natl. Acad. Sci. USA 93: 11895–11900.
   PubMed Web of Science ®Google Scholar
• Sasaki, K., H. Yagi, R. T. Bronson, K. Tominaga, T. Matsunashi, K. Deguchi, Y. Tani, T. Kishimoto, and T. Komori 1996. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc. Natl. Acad. Sci. USA 93: 12359–12363.
   PubMed Web of Science ®Google Scholar
• Scott, L. M., C. I. Civin, P. Rorth, and A. D. Friedman 1992. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80: 1725–1735.
   PubMed Web of Science ®Google Scholar
• Speck, N. A., and T. Stacy 1995. A new transcription factor family associated with human leukemias. Crit. Rev. Eukaryotic Gene Expr. 5: 337–364.
   PubMed Web of Science ®Google Scholar
• Tanaka, T., M. Kurokawa, K. Ueki, K. Tanaka, Y. Imai, K. Mitani, K. Okazaki, N. Sagata, Y. Yazaki, Y. Shibata, T. Kadowaki, and H. Hirai 1996. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol. Cell. Biol. 16: 3967–3979.
   PubMed Web of Science ®Google Scholar
• Wang, S., Q. Wang, B. E. Crute, I. N. Melnikova, S. R. Keller, and N. A. Speck 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13: 3324–3339.
   PubMed Web of Science ®Google Scholar
• Wang, Q., T. Stacy, M. Binder, M. Marin-Padilla, A. H. Sharpe, and N. A. Speck 1996. Disruption of the cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93: 3444–3449.
   PubMed Web of Science ®Google Scholar
• Wang, Q., T. Stacy, J. D. Miller, A. F. Lewis, T.-L. Gu, X. Huang, J. H. Bushweller, J.-C. Bories, F. W. Alt, G. Ryan, P. P. Liu, A. Wynshaw-Boris, M. Binder, M. Marin-Padilla, A. H. Sharpe, and N. A. Speck 1996. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 87: 697–708.
   PubMed Web of Science ®Google Scholar
• Webster, N., J. R. Jin, S. Green, M. Hollis, and P. Chambon 1988. The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52: 169–178.
   PubMed Web of Science ®Google Scholar
• Yergeau, D. A., C. J. Hetherington, Q. Wang, P. Zhang, A. H. Sharpe, M. Binder, M. Marin-Padilla, D. G. Tenen, N. A. Speck, and D. E. Zhang 1997. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15: 303–306.
   PubMed Web of Science ®Google Scholar
• Zeng, C., A. J. van Wijnen, J. L. Stein, S. Meyers, W. Sun, L. Shopland, J. B. Lawrence, S. Penman, J. B. Lian, G. S. Stein, and S. W. Hiebert 1997. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-α transcription factors. Proc. Natl. Acad. Sci. USA 94: 6746–6751.
   PubMedGoogle Scholar
• Zhang, D. E., C. J. Hetherington, H. M. Chen, and D. G. Tenen 1994. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell. Biol. 14: 373–381.
   PubMedGoogle Scholar
• Zhang, D. E., C. J. Hetherington, S. Meyers, K. L. Rhoades, C. J. Larson, H. M. Chen, S. W. Hiebert, and D. G. Tenen 1996. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16: 1231–1240.
   PubMed Web of Science ®Google Scholar
• Zhang, Y. W., S. C. Bae, G. Huang, Y. X. Fu, J. Lu, M. Y. Ahn, Y. Kanno, T. Kanno, and Y. Ito 1997. A novel transcript encoding an N-terminally truncated AML1/PEBP2αB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Mol. Cell. Biol. 17: 4133–4145.
   PubMedGoogle Scholar
• Zhang, Y. W., S.-C. Bae, E. Takahashi, and Y. Ito 1997. The cDNA cloning of the transcripts of human PEBP2αA/CBFA1 mapped to 6p12.3–p12.1, the locus for cleidocranial dysplasia. Oncogene 15: 367–371.
   PubMedGoogle Scholar